Skip to main content

Table 2 Summary of the largest original investigations on long-term risk of mortality or ESRD in adult patients who experienced AKI

From: The aftermath of acute kidney injury: a narrative review of long-term mortality and renal function

Author

Setting

Population

Number

Follow-up

AKI definition

Adjusted risk

Comments

A. Long-term risk of mortality

 Bihorac et al. [33]

ICU (surgical)

Hospital survivors

10,518

Max 14 years

RIFLE criteria

R

I

F

HR (95% CI) = 1.18 (1.08–1.29)

HR (95% CI) = 1.43 (1.29–1.59)

HR (95% CI) = 1.57 (1.40–1.75)

–

 Coca et al. [34]

Noncardiac surgery

Hospital survivors

35,302

Mean 3.7 years

AKIN criteria

I

II

III

HR (95% CI) = 1.24 (1.17–1.31)

HR (95% CI) = 1.64 (1.43–1.88)

HR (95% CI) = 1.96 (1.63–2.37)

Only diabetic veterans included.

 Fuchs et al. [35]

ICU (overall)

60-day survivors

12,399

Max 2.0 years

AKIN criteria

I

II

III

HR (95% CI) = 1.26 (1.14–1.40)

HR (95% CI) = 1.28 (1.11–1.47)

HR (95% CI) = 1.61 (1.30–1.99)

–

 Ishani et al. [36]

Overall hospitalization

Hospital survivors

233,803

Max 2.3 years

ICD-9 code

AKI

HR (95% CI) = 2.38 (2.31–2.46)

Only elderly patients ≥ 67 years of age included.

 James et al. [37]

Coronary angiography

All patients

14,782

Median 1.6 years

AKIN criteria

I

II/III

HR (95% CI) = 2.00 (1.69–2.36)

HR (95% CI) = 3.72 (2.92–4.76)

–

 Lafrance et al. [38]

Overall hospitalization

90-day survivors

864,933

Mean 2.3 years

AKIN criteria

I

II

III

HR (95% CI) = 1.36 (1.34–1.38)

HR (95% CI) = 1.46 (1.42–1.50)

HR (95% CI) = 1.59 (1.54–1.65)

Only veterans included. AKI requiring RRT excluded.

 Liotta et al. [39]

CABG

All patients

25,665

Mean 6.0 years

Mild ΔSCr 0.0–0.3 mg/dl

Moderate ΔSCr 0.3–0.5 mg/dl

Severe ΔSCr ≥ 5.0 md/dl

Mild

Moderate

Severe

HR (95% CI) = 1.07 (1.00–1.15)

HR (95% CI) = 1.33 (1.19–1.48)

HR (95% CI) = 2.11 (1.92–2.32)

–

 Parikh et al. [40]

AMI

Hospital survivors

147,007

Max 10.0 years

Mild ΔSCr 0.3–0.4 mg/dl

Moderate ΔSCr 0.5–0.9 mg/dl

Severe ΔSCr ≥ 1.0 md/dl

Mild

Moderate

Severe

HR (95% CI) = 1.15 (1.12–1.18)

HR (95% CI) = 1.23 (1.20–1.26)

HR (95% CI) = 1.33 (1.28–1.38)

Only elderly patients ≥ 65 years of age included.

 Rimes-Stigare et al. [41]

ICU (overall)

All patients

103,363

Median 2.1 years

Temporary RRT or ICD-10 code or ARF reported in APACHE score or serum creatinine > 354 μmol/L

AKI

MMR (95% CI) = 1.15 (1.09–1.21)

–

 Ryden et al. [42]

CABG

All patients

27,929

Mean 5.0 years

Mild ΔSCr 0.3–0.4 mg/dl

Moderate ΔSCr 0.5–0.9 mg/dl

Severe ΔSCr ≥ 1.0 md/dl

Mild

Moderate

Severe

HR (95% CI) = 1.30 (1.17–1.44)

HR (95% CI) = 1.65 (1.48–1.83)

HR (95% CI) = 2.68 (2.37–3.03)

–

B. Long-term risk of ESRD

 Ishani et al. [36]

Overall hospitalization

Hospital survivors

233,803

Max 2.3 years

ICD-9 code

AKI

HR (95% CI) = 6.74 (5.90–7.71)

Only elderly patients ≥ 67 years of age included.

 James et al. [37]

Coronary angiography

All patients

14,782

Median 1.6 years

AKIN criteria

I

II/III

HR (95% CI) = 4.15 (2.32–7.42)

HR (95% CI) = 11.74 (6.38–21.59)

–

 Rimes-Stigare et al. [41]

ICU (overall)

All patients

103,363

Median 2.1 years

Temporary RRT or ICD-10 code or ARF reported in APACHE score or serum creatinine > 354 μmol/L

AKI

IRR (95% CI) = 24.1 (13.9–42.0)

–

 Ryden et al. [61]

CABG

All patients

29,330

Mean 4.3 years

AKIN criteria

I

II/III

HR (95% CI) = 2.92 (1.87–4.55)

HR (95% CI) = 3.81 (2.14–6.79)

–

  1. This table includes only studies with > 10,000 patients. Studies that only evaluated the impact of AKI requiring RRT are not included
  2. AKI acute kidney injury, AKIN Acute Kidney Injury Network, AMI acute myocardial infarction, APACHE Acute Physiology And Chronic Health Evaluation, ARF acute renal failure, CABG coronary artery bypass grafting, CI confidence interval, HR hazard ratio, ICD International Classification of Diseases, ICU intensive care unit, IRR incidence rate ratio, MMR mortality rate ratio, RIFLE Risk, Injury, Failure, Loss, End-stage Renal Disease, RRT renal replacement therapy, SCr serum creatinine concentration